Wadsworth Center’s Bacteriology Laboratory Plays a Pivotal Role in New York City's Legionella Outbreak

The Wadsworth Center’s Bacteriology Laboratory played a pivotal role in the recent Legionella outbreak in New York City. The classical approach to Legionella testing is culture, but, as Legionella are slow growing and fastidious organisms and the water samples are usually heavily contaminated with other bacteria, obtaining results can take a long time, delaying the required public health response. In order to support more rapid decision making, Dr.

National Center for Adaptive Neurotechnologies (NCAN) Open House

Commissioner of Health, Dr. Howard Zucker reflected that Brain Computer Interface (BCI) technology frees those who, like Stephen Hawking, are locked-in by allowing the silent to speak and the immobile to move. It aids those with injury, illness and stroke by taking advantage of lifelong brain plasticity that not long ago we didn’t realize existed. With the use of hardware and software, thoughts can control a keyboard enabling the user to text, email or move a wheelchair.

Newborn Screening Program Pilot Study: Hurler Syndrome

The New York State Newborn Screening Program screens all infants born in the state for 47 different diseases. In addition, the program is currently performing a pilot study with Dr. Melissa Wasserstein (pictured left), from the Icahn School of Medicine at Mount Sinai, to screen for four additional diseases that are lysosomal storage disorders (LSDs). Four New York City hospitals are participating and approximately 500 infants are being tested weekly in the pilot study.  The newest disorder to be tested is called Hurler syndrome.

Lieutenant Governor Kathy Hochul Visits Wadsworth Center's David Axelrod Institute for Public Health

On Monday June 15th the Lieutenant Governor, the Honorable Kathy Hochul, visited the David Axelrod Institute. She had specifically asked to learn more about our preparedness and biodefense activities, so the first stop was a tour of the Biodefense Laboratory. Dr. Christina Egan described the laboratory’s capabilities to detect agents-of-concern in white powders, as well as other environmental samples, and the major push in the development and evaluation of new technologies since the anthrax attacks of 2001.

Cystic Fibrosis Foundation Funds Collaborative Newborn Screening Project at the Wadsworth Center

The Newborn Screening Program at the Wadsworth Center has been awarded a two-year Cystic Fibrosis Foundation Screening Improvement Program (SIP) grant titled CF-GENES-II: Improving Genetic Counseling Access for Caregivers of Infants with Cystic Fibrosis Newborn Screen-Positive, Inconclusive Diagnosis in New York State.The Wadsworth Center screens every infant born in New York State for cystic fibrosis (CF). Infants with positive screening results are referred to one of the state’s specialty care centers for diagnostic testing, clinical evaluation, treatment, and follow-up.

Enterovirus Molecular Characterization Training for Public Health Laboratories Held at Wadsworth Center

The Laboratory of Viral Diseases hosted a two-day enterovirus molecular characterization workshop on July 28th and 29th. The training was sponsored by the Association of Public Health Laboratories (APHL) and included scientists from state public health laboratories in New Jersey, Oregon, Michigan, Washington, California, Massachusetts, and Nebraska.  

New Funding for Wadsworth Center’s Mycobacterium tuberculosis Whole Genome Sequencing

The Wadsworth Center has been awarded funding through the Epidemiology and Laboratory Capacity (ELC) Grant Program’s Antimicrobial Laboratory Network to support antimicrobial-resistant Mycobacterium tuberculosis activities from August 1, 2025 – July 31, 2026.  Two state public health laboratories, including the Wadsworth Center’s Mycobacteriology Laboratory, were selected to conduct whole genome sequencing (WGS) for culture-positive tuberculosis (TB) cases within their states. 

New York State Newborn Screening Program at the Wadsworth Center Selected for BEACONS Genome Sequencing Study

The New York State Newborn Screening Program at the Wadsworth Center has been selected to participate in BEACONS (Building Evidence and Collaboration for GenOmics in Nationwide Newborn Screening), a national research study evaluating the use of optional, supplemental newborn genome sequencing within existing public health newborn screening systems. The goal of BEACONS is to assess how genome sequencing can be responsibly, equitably, and sustainably integrated into public health newborn screening programs across the United States.

New York State's Wastewater Surveillance System Named 'Center of Excellence' by CDC

The State Health Department's Wastewater Surveillance Program  is integral to advanced COVID-19 tracking and nation-leading polio detection efforts. The program is now testing for Influenza, RSV, Hepatitis A, Norovirus and antimicrobial-resistant genes.Read the New York State Department of Health's press release.

Podcast Feature: Decoding a Legionnaires’ Outbreak in New York City with Wadsworth Scientist Dr. Kimberlee Musser

A new episode of the Inspired to Heal podcast, hosted by Dr. William (Bill) Trick – retired in 2024 after a distinguished career as a clinician, researcher, and CDC epidemiologist – features Wadsworth Center’s Dr. Kimberlee Musser alongside Dr. Don Weiss of the New York City Department of Health and Mental Hygiene.  

Positive Outcomes from the Wadsworth Center Visiting Scholar Program

The Wadsworth Center’s Visiting Scholar Program continues to demonstrate strong international impact and scientific value. Two visiting scientists from Mahidol University in Bangkok, Thailand, who completed their year-long training earlier this year, have provided highly positive reports of their experience in the laboratories of the Wadsworth Center.